DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Reed SD, Dinan MA, Schulman KA et al.
Cost-effectiveness of the 21-gene recurrence score assay in the setting of
multifactorial decision making for chemotherapy in early-stage breast
cancer.
J Clin Oncol 2012;
30 (Suppl.) Abstr. 1525
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.